This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Newman Ferrara LLP Announces Investigation Of Ceradyne, Inc.

Newman Ferrara LLP has begun an investigation into potential claims against the Board of Directors of Ceradyne, Inc. (“Ceradyne”) (Nasdaq: CRDN) concerning the proposed acquisition of Ceradyne by 3M Co. (“3M”) (NYSE: MMM).

On October 1, 2012, Ceradyne announced that it had entered into an agreement and plan of merger to be acquired by 3M in an all cash deal valued at approximately $670 million. Under the terms of the agreement, Ceradyne’s shareholders will receive $35.00 in cash for each share of Ceradyne stock owned. However, Ceradyne common stock has traded at a 52-week high of $36.61 per share and has traded at $49.91 per share as recently as May 11, 2011.

Ceradyne’s Board of Directors has unanimously approved the proposed merger agreement which is expected to close before the end of this year.

Newman Ferrara LLP’s investigation concerns whether Ceradyne’s Board of Directors has breached its fiduciary duties to act in the best interests of Ceradyne’s shareholders and to take all necessary steps to ensure that Ceradyne’s shareholders receive the maximum value readily available for their shares of Ceradyne common stock.

Concerned investors are encouraged to contact Newman Ferrara attorney Roy Shimon at (212) 619-5400 or to discuss this investigation, their rights, or potential remedies.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs